US NYSE stock alert

USA

CLOSING UPDATE: Johnson and Johnson hits 52-week high sixth time in one month 20 October 2017 18:07 EDT

NEWS BITES - NORTH AMERICA

This is an end of day Alert, produced after today's NYSE market close. It concludes the BSS News Bites intra-day Alert series (summaries below).

Johnson and Johnson, NYSE's largest pharmaceuticals company by market capitalisation, hit a 52-week high of $US143.62 today for the sixth time in the past one month and last traded at $US142.40. This brought its two-day rise to $US1.72 or 1.2%. Trading volume was 93% of average at the end of the day. Compared with the S&P 500 Index which rose 13.1 points (or 0.5%) in the day, this represented a relative price change of -0.3%.

Technical indicators complementing today's significant uptrend:

+ The positive 2.38 MACD (Moving Average Convergence Divergence) indicator suggests a bullish signal.

+ The stock has outperformed 81% of the NYSE market over the past 6 months.

+ In the last one month the stock has hit a new 52-week high six times and in the last three months seven times, pointing to a significant uptrend.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Undervaluation:

+ Price/Earnings of 24.0 [28.6]

+ Price/Earnings/Growth of 3.2 [8.2]

+ Return on Equity 23.5% [14.1%]

+ Return on Assets 11.7% [5.7%]

+ Return on Capital Employed 17.9% [8.3%]

+ Year-on-Year Earnings Growth of 8.2% [3.5%]

Other Bullish Signals include:

+ Interest cover is less leveraged at 28.3 times.

+ Total Liabilities/EBITDA of 3.4 is comfortably below the Joseph Piotroski benchmark of <5.

+ The Brand Value represents 2.1% of the estimated Enterprise Value of $US390.4 billion.

+ As per the Du Pont analysis, Return on Equity is high at 23.5%. Also, this has improved from 21.7% last year.

Note

Bearish Signals:

Tobin's Q Ratio is 2.7. Compared with the rest of the market the stock is overvalued and ranks in the bottom quartile of stocks by value of Q Ratio.

Overbought/Bearish:

The 0.8% discount to 12-month high of $US143.62 against the 32.8% premium to 12-month low of $US107.20 suggests the climb might be peaking.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Overvaluation:

Price/Sales of 5.3 [4.1]

Dividend yield of 2.3% [2.6%]

TODAY'S ALERTS

Afternoon Alert: Johnson and Johnson hits 52-week high sixth time in one month

20 October 2017 13:05 EDT

Johnson & Johnson (NYSE:JNJ) hit a 52-week high of $US143.62 today for the sixth time in the past one month and last traded at $US141.98. Trading volume was 74% of average so far today.

Morning Alert: Johnson and Johnson up 2.0% in 2 days

20 October 2017 11:15 EDT

Johnson & Johnson (NYSE:JNJ) extended its gains on Friday, rising an additional $US1.47 (or 1.0%) to trade at $US143.51. Trading volume was 79% of average so far today. The shares have risen $US2.83 (or 2.0%) over the past two trading days vs. the S&P 500 Index which has risen 0.3% in the same period.

RECENT ALERTS

CLOSING UPDATE: Johnson and Johnson increases further 0.3%, led Pharmaceuticals sector higher

19 October 2017 18:05 EDT

Johnson and Johnson, NYSE's largest pharmaceuticals company by market capitalisation, has increased 1.0% to trade at $US142.04 vs. the Pharmaceuticals sector which strengthened 20.6 points (or 0.9%) to 2,300.7. Representing a weighting of about 34.4% of the sector, the stock accounted for 36.9% of today's gain. The shares have outperformed 94% of the market in the past week. Trading volume was 1.4 times average at the end of the day. Compared with the S&P 500 Index which fell 0.5 points (or 0.02%) in the day, this represented a relative price increase of 1.0%.

Afternoon Alert: Johnson and Johnson increases 0.6%, leads Pharmaceuticals sector higher

19 October 2017 13:05 EDT

Johnson & Johnson (NYSE:JNJ) has increased 0.6% to trade at $US141.54 vs. the Pharmaceuticals sector which strengthened 13.4 points (or 0.6%) to 2,293.4. Representing a weighting of about 34.3% of the sector, the stock accounted for 35.6% of today's gain. The shares have outperformed 89% of the market in the past week. Trading volume was 1.2 times average so far today.

Johnson & Johnson (N:JNJ)

ISIN: US4781601046

PermID: 4295904341

CIK: 200406

CUSIP: 478160104

Source: www.BuySellSignals.com